LBA49_PR - Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from the RADICALS RT randomised controlled trial (RCT) [NCT00541047] von Parker, C., Clarke, N.W., Cook, A., Kynaston, H.G., Meidahl Petersen, P., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H., Saad, F., Brasso, K., Lindberg, H., Zarkar, A., Raman, R., Roder, M.A., Heath, C., Parulekar, W.R., Parmar, M.K.B., Sydes, M.R.

Volltext

Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from the RADICALS RT randomised controlled trial (RCT) [NCT00541047] von Parker, C., Clarke, N.W., Cook, A., Kynaston, H.G., Meidahl Petersen, P., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H., Saad, F., Brasso, K., Lindberg, H., Zarkar, A., Raman, R., Roder, M.A., Heath, C., Parulekar, W.R., Parmar, M.K.B., Sydes, M.R.

Volltext

Danish Prostate Cancer Registry - methodology and early results from a novel national database von Helgstrand, J T, Klemann, N, Røder, M A, Toft, B G, Brasso, K, Vainer, B, Iversen, P

Volltext

Vitamin D level and mortality risk among Danish men with prostate cancer von Stroomberg, H.V., Juhl Vojdeman, F., Medom Madsen, C., Helgstrand, J.T., Schwarz, P., Heegaard, A-M., Hansen, L., Olsen, A., Tjønneland, A., Struer Lind, B., Brasso, K., Løvendahl Jørgensen, H., Røder, M.A.

Volltext

1764O Timing of radiotherapy (RT) after radical prostatectomy (RP): Final results of RADICALS RT randomised controlled trial von Parker, C., Clarke, N., Cook, A., Kynaston, H., Meidahl Petersen, P., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H.A., Saad, F., Brasso, K., Heath, C., Lindberg, H., Raman, R., Røder, M.A., Zarkar, A., Parulekar, W.R., Parmar, M.K., Sydes, M.R.

Volltext

Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit in an ERAS setup (BORARC): A double-bli... von Maibom, S.L., Røder, M.A., Aasvang, E.K., Rohrsted, M., Thind, P.O., Bagi, P., Kistorp, T., Poulsen, A.M., Salling, L.N., Kehlet, H., Brasso, K., Joensen, U.N.

Volltext

Risk of prostate cancer mortality in men with an initial benign needle core biopsy set: a population based analysis with up to 20 years of follow-up von Klemann, N., Helgstrand, J.T., Brasso, K., Vainer, B., Toft, B.G., Røder, M.A., Iversen, P.

Volltext

179P Impact of exercise training on tumour-infiltrating T cells in human prostate cancer von Lehrskov, L.L., Nørskov Thomsen, S., Stærk, M. Garder, Wriedt, E., Djurhuus, S. Sigmundsdottir, Toft, B. Grønkær, Wielsøe, S., Røder, M.A., Hasselager, T., Oestergren, P. Busch, Jakobsen, H., Pedersen, B. Klarlund, Hojman, P., Brasso, K., Christensen, J. Frank, Simonsen, C.

Volltext

Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from RADICALS RT randomised controlled trial [NCT00541047] von Parker, C., Clarke, N.W., Cook, A., Kynaston, H., Petersen, P.M., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H., Saad, F., Brasso, K., Lindberg, H., Zarkar, A., Raman, R., Roder, M.A., Heath, C., Parulekar, W., Parmar, M., Sydes, M.

Volltext

P162 - Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from RADICALS RT randomised controlled trial [NCT00541047] von Parker, C., Clarke, N.W., Cook, A., Kynaston, H., Petersen, P.M., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H., Saad, F., Brasso, K., Lindberg, H., Zarkar, A., Raman, R., Roder, M.A., Heath, C., Parulekar, W., Parmar, M., Sydes, M.

Volltext

The CPC risk calculator app: A validated tool to predict recurrence after radical prostatectomy von Røder, M.A, Berg, K.D, Loft, M.D, Gerds, T.A, Ferrari, M, Thomsen, F.B, Gruschy, L, Kurbegovic, S, Rytgaard, H.C, Kjær, A, Brasso, K, Iversen, P, Brooks, J

Volltext

529 ERG protein expression is not an independent risk-factor for development of castration-resistant prostate cancer in advanced and metastatic disease treated with androgen depriv... von Berg, K.D, Røder, M.A, Thomsen, F.B, Vainer, B, Gerds, T.A, Brasso, K, Iversen, P

Volltext

432 A novel model to estimate a patient's individual risk of biochemical recurrence after radical prostatectomy von Røder, M.A, Berg, K.D, Thomsen, F.B, Kurbegovic, S, Rytgaard, H.C, Gruschy, L, Brasso, K, Gerds, T.A, Iversen, P

Volltext

427 Urokinase plasminogen activator receptor (uPAR) assessment in localized-, hormone naïve-, and castration resistant prostate cancer von Lippert, S, Berg, K.D, Høyer-Hansen, G, Iversen, P, Christensen, I.J, Brasso, K, Røder, M.A

Volltext

345 ERG-expression is an independent predictor of disease progression during active surveillance von Berg, K.D, Vainer, B, Thomsen, F.B, Røder, M.A, Toft, B.G, Brasso, K, Iversen, P

Volltext

273 Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme? von Thomsen, F.B, Christensen, I.J, Røder, M.A, Brasso, K, Iversen, P

Volltext

1171 - The hazard of depression after radical prostatectomy – a nationwide registry-based study von Friberg, A.S., Brasso, K., Andersen, E.W., Helgstrand, J.T., Röder, M.A., Johansen, C., Dalton, S.O.

Volltext

Changes in Gleason score misclassification between diagnostic biopsies and radical prostatectomy specimens – a nationwide analysis von Helgstrand, J.T., Røder, M.A., Klemann, N., Kawa, S.M., Toft, B.G., Brasso, K.

Volltext

The hazard of depression after radical prostatectomy – a nationwide registry-based study von Friberg, A.S., Brasso, K., Andersen, E.W., Helgstrand, J.T., Röder, M.A., Johansen, C., Dalton, S.O.

Volltext

155 - Changes in Gleason score misclassification between diagnostic biopsies and radical prostatectomy specimens – a nationwide analysis von Helgstrand, J.T., Røder, M.A., Klemann, N., Kawa, S.M., Toft, B.G., Brasso, K.

Volltext